LCM
Laurion Capital Management Portfolio holdings
AUM
$867M
This Quarter Return
-1.67%
1 Year Return
+5.19%
3 Year Return
+14.26%
5 Year Return
+18.43%
10 Year Return
+26.97%
AUM
$3.07B
AUM Growth
+$3.07B
(-15%)
Cap. Flow
-$259M
Cap. Flow
% of AUM
-8.43%
Top 10 Holdings %
Top 10 Hldgs %
53.48%
Holding
600
New
258
Increased
39
Reduced
96
Closed
156
Top Buys
| 1 |
HES
Hess
HES
|
$346M |
| 2 |
X
US Steel
X
|
$170M |
| 3 |
HubSpot
HUBS
|
$167M |
| 4 |
ANSS
Ansys
ANSS
|
$166M |
| 5 |
Chevron
CVX
|
$141M |
Top Sells
| 1 |
Kenvue
KVUE
|
$128M |
| 2 |
Adobe
ADBE
|
$97.4M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
$84M |
| 4 |
BP
BP
|
$78.5M |
| 5 |
Apple
AAPL
|
$71.3M |
Sector Composition
| 1 | Technology | 29.42% |
| 2 | Healthcare | 20.77% |
| 3 | Energy | 16.72% |
| 4 | Consumer Discretionary | 8.58% |
| 5 | Financials | 8.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
AbbVie
ABBV
$374B
| $5.02M | 0.06% |
+29,271
| New | +$5.02M |
|
77
Icon
ICLR
$14B
| $5M | 0.06% |
+15,952
| New | +$5M |
|
78
GE Aerospace
GE
$293B
| $4.75M | 0.06% |
+29,899
| New | +$4.75M |
|
79
Nuvation Bio
NUVB
$1.08B
| $4.65M | 0.06% |
+1,591,475
| New | +$4.65M |
|
80
Trade Desk
TTD
$26.3B
| $4.53M | 0.05% |
+46,400
| New | +$4.53M |
|
81
Super Micro Computer
SMCI
$23.8B
| $4.46M | 0.05% |
+54,460
| New | +$4.46M |
|
82
Berkshire Hathaway Class B
BRK.B
$1.08T
| $4.37M | 0.05% |
+10,743
| New | +$4.37M |
|
83
Costco
COST
$421B
| $4.36M | 0.05% |
+5,133
| New | +$4.36M |
|
84
RTX Corp
RTX
$212B
| $4.05M | 0.05% |
40,361
-165,702
| -80% | -$16.6M |
|
85
Apollo Global Management
APO
$75.9B
| $4.01M | 0.05% |
+33,963
| New | +$4.01M |
|
86
Bio-Techne
TECH
$8.3B
| $3.71M | 0.04% |
51,717
-1,600
| -3% | -$115K |
|
87
SPDR S&P Regional Banking ETF
KRE
$3.97B
| $3.57M | 0.04% |
+72,800
| New | +$3.57M |
|
88
McDonald's
MCD
$226B
| $3.55M | 0.04% |
13,932
-147,524
| -91% | -$37.6M |
|
89
Altria Group
MO
$112B
| $3.4M | 0.04% |
74,751
+71,701
| +2,351% | +$3.27M |
|
|
CMPS
90
Compass Pathways
CMPS
$452M
| $3.09M | 0.04% |
510,907
| – | – |
|
|
BBOT
91
BridgeBio Oncology Therapeutics, Inc. Common Stock
BBOT
$779M
| $3.07M | 0.04% |
300,000
| – | – |
|
92
Rubrik
RBRK
$17B
| $2.94M | 0.03% |
+95,893
| New | +$2.94M |
|
93
Citigroup
C
$175B
| $2.94M | 0.03% |
+46,285
| New | +$2.94M |
|
94
Acumen Pharmaceuticals
ABOS
$82.4M
| $2.85M | 0.03% |
1,178,338
-716,685
| -38% | -$1.73M |
|
95
Jefferies Financial Group
JEF
$13.2B
| $2.83M | 0.03% |
56,778
-1,258
| -2% | -$62.6K |
|
96
Solid Biosciences
SLDB
$448M
| $2.78M | 0.03% |
489,678
-438,491
| -47% | -$2.49M |
|
97
Nordson
NDSN
$12.5B
| $2.72M | 0.03% |
11,720
+1,383
| +13% | +$321K |
|
98
UroGen Pharma
URGN
$896M
| $2.69M | 0.03% |
160,600
-90,000
| -36% | -$1.51M |
|
99
Fidelity National Information Services
FIS
$35.6B
| $2.67M | 0.03% |
+35,428
| New | +$2.67M |
|
100
Amgen
AMGN
$153B
| $2.62M | 0.03% |
+8,387
| New | +$2.62M |
|